Akebia Therapeutics, Inc. Retention Agreements
10 Contracts & Agreements
- February 2024 Amendment to Retention and Separation Agreement for Michel Dahan (Filed With SEC on March 14, 2024)
- February 2024 Amendment to Retention and Separation Agreement for Nicole R. Hadas (Filed With SEC on March 14, 2024)
- October 2023 Amendment to Retention and Separation Agreement for Nicole R. Hadas (Filed With SEC on November 8, 2023)
- July 2023 Amendment to Retention and Separation Agreement for Nicole R. Hadas (Filed With SEC on August 28, 2023)
- July 2023 Amendment to Retention and Separation Agreement for Michel Dahan (Filed With SEC on August 28, 2023)
- Form of May 2023 Amendment to Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas (Filed With SEC on August 28, 2023)
- Form of Amendment to Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas (Filed With SEC on November 3, 2022)
- Retention Agreement with David Spellman, dated June 22, 2022 (Filed With SEC on August 4, 2022)
- Form of Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas (Filed With SEC on May 9, 2022)
- Form of Officer Retention Letter Agreement (Filed With SEC on May 9, 2022)